Capricor Therapeutics, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation

Core Viewpoint - Johnson Fistel, PLLP is investigating potential legal claims on behalf of Capricor Therapeutics, Inc. shareholders regarding alleged misconduct by certain officers and directors that may have harmed the company and its investors [1]. Group 1: Legal Investigation - The investigation focuses on potential legal claims related to misconduct by Capricor's officers and directors [1]. - Investors who held Capricor shares since before October 9, 2024, may have legal rights and are encouraged to contact Johnson Fistel for more information [2]. Group 2: Company Background - Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, and Colorado [3]. - The firm has recovered over $90 million for clients and is recognized among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services [3].